Klein R,Knudtson MD,Lee KE,Gangnon R,Klein BE,-1868 Zhang X,Zeng H,Bao S,Wang N,Gillies MC .2016 .Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci, 4(3) : 27.
Hakeem R,Fawwad A,Bhagat N,Grigorian RA,Tutela A,Zarbin MA .2019 .Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol, 54(1) : 1-32.
Funatsu H,Noma H,Mimura T,Eguchi S,Hori S.,Pognuz R,Polito A,Pirracchio A,Menchini F,Ambesi M. .2016 .Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology, 116(1) : 73-79.
Zhang X,Bao S,Lai D,Rapkins RW,Gillies MC .2018 .Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes, 57(4) : 1026-1033.
Ghoraba HH,Leila M,Elgouhary SM,Elgemai EEM,Abdelfattah HM,Ghoraba HH,Tayyab H,Ahmed N H,Sadiq A.A.M. H .2020 .Efficacy and safety of Suprachoroidal Triamcinolone Acetonide in cases of resistant diabetic Macular Edema. Pak J Med Sci, 36(2) : 42-47.
Goldstein DA,Do D,Noronha G,Kissner JM,Srivastava SK,Nguyen QD .2016 .Suprachoroidal Corticosteroid Administration:A Novel Route for Local Treatment of Noninfectious Uveitis. Transl Vis Sci Technol, 5(6) : 14.
Fong DS,Ferris FL,Davis MD,Chew EY .1999 .Causes of severe visual loss in the early treatment diabetic retinopathy study. ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol, 127(2) : 137-141.
Striph GG,Hart WM .1988 .Modified grid laser photocoagulation for diabetic macular edema. The effect on the central visualfield. Ophthalmology, 95(12) : 1673-1679.
Lim JW,Lee HK,Shin MC .2012 .Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Ophthalmologica, 227(2) : 100-106.
Song HJ,Lee JJ,Lee SJ .2011 .Comparison of the Short-Term Effects of IVTA and Bevacizumab Injection for Diabetic Macular Edema. Korean J Ophthalmol, 25(3) : 156-160.
Isaac DL,Abud MB,Frantz KA,Rassi AR,Avila M. Comparing,Sutter FK,Simpson JM,Gillies MC .2004 .Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology, 111(11) : 2044-2049.
.2008 .Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study) Br J Ophthalmol. , 92(1) : 76-80.
Ophir A ,Kreutzer TC,Al Saeidi R,Kook D,Wolf A,Ulbig MW,Neubauer AS,Haritoglou C .2010 .Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema. Ophthalmologica, 224(4) : 258-264.
.2013 .Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis. Int J Ophthalmol, 6(4) : 546-552.
Christoforidis JB,Carlton MM,Knopp MV,Hinkle GH,Shimura M,Nakazawa T,Yasuda K,Shiono T,Lida T,Sakamoto T,Nishida K. .2008 .Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol, 145(5) : 854-861.
Marey HM,Ellakwa AF .2011 .Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema. Clin Ophthalmol, 5 : 1011-1016.